Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Angle presents positive pre-natal testing study results in Massachusetts

Monday, 29th October 2018
Biopsy company Angle said it had gotten positive results from a pilot study of technology that harvests fetal cells from the peripheral blood of pregnant women to detect fetal abnormalities.

The results were being presented on Monday at the 6th Annual Advances in Prenatal Diagnostics conference in Cambridge, Massachusetts.

The company's so-called Parsortix system provided a more comprehensive diagnosis of fetal abnormalities for mothers at risk of an affected pregnancy, according to founder and chief executive Andrew Newland.

'Angle's product-based approach to liquid biopsy enables us to leverage partnerships with third parties, which we are developing in the NIPT space, an established and fast-growing large scale market,' Newland said.

At 2:12pm: (LON:AGL) Angle PLC share price was +3p at 42.5p

Story provided by

Related Shares: Angle

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.